How should DSM-V criteria for schizophrenia include cognitive impairment?
about
Will the Kraepelinian dichotomy survive DSM-V?Cortical parvalbumin interneurons and cognitive dysfunction in schizophreniaThe involvement of Type II Neuregulin-1 in rat visuospatial learning and memorynAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancyPrenatal exposure to a viral mimetic alters behavioural flexibility in male, but not female, rats.The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far?The self-assessment scale of cognitive complaints in schizophrenia: a validation study in Tunisian population.Cognitive impairment in affective psychoses: a meta-analysisCognitive impairment in schizophrenia and affective psychoses: implications for DSM-V criteria and beyond.Anticipating DSM-V: opportunities and challenges for cognition and psychosisGeneral and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance.Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability.Neurological abnormalities in recent-onset schizophrenia and asperger-syndrome.Early developmental disturbances of cortical inhibitory neurons: contribution to cognitive deficits in schizophrenia.Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia.Neurobiology of cognitive remediation therapy for schizophrenia: a systematic reviewThe Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.Antidepressants for cognitive impairment in schizophrenia--a systematic review and meta-analysis.Nitric oxide synthase mediates the ability of darbepoetin alpha to improve the cognitive performance of STOP null miceThe screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients.Empirical support for DSM-IV schizoaffective disorder: clinical and cognitive validators from a large patient sample.Cognitive remediation improves cognition and good cognitive performance increases time to relapse--results of a 5 year catamnestic study in schizophrenia patients.Impaired visual object processing across an occipital-frontal-hippocampal brain network in schizophrenia: an integrated neuroimaging studyGene expression profiling in rodent models for schizophrenia.How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features.Treatment of early onset schizophrenia: recent trends, challenges and future considerations.The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosisThe Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric PropertiesCortical circuit dysfunction and cognitive deficits in schizophrenia--implications for preemptive interventions.Comparison of Visuospatial and Verbal Abilities in First Psychotic Episode of Schizophrenia Spectrum Disorder: Impact on Global Functioning and Quality of Life.Structural neurobiological correlates of Mayer-Salovery-Caruso Emotional Intelligence Test performance in early course schizophrenia.Neuroanatomical substrates of foresight in schizophrenia.Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophreniaBridging the gap between schizophrenia and psychotic mood disorders: Relating neurocognitive deficits to psychopathology.Potential enhancing effects of histamine H₁ agonism/H₃ antagonism on working memory assessed by performance and bold response in healthy volunteersNeurobiology of the early course of schizophrenia.Neuroanatomical Differences between First-Episode Psychosis Patients with and without Neurocognitive Deficit: A 3-Year Longitudinal Study
P2860
Q24656868-9C6B935D-1DAA-4C55-8EA7-1CAEADDC01C4Q26822851-5C31217C-0257-4D7D-8243-4F8C37DC46B0Q28568053-5CA84632-D6DE-414C-8782-F96A73F4F4DFQ30362464-ABB0A163-9221-44CA-9043-87D5C82EE6D7Q30409382-6DB5FD85-576C-4B72-8800-CBADAFF245E6Q30409892-49957B41-E7D2-4400-A333-DC698AB9126EQ30479463-A4134748-5F64-48F1-8704-5D02DE84110CQ30536299-ADC6FA37-FA9A-4F7F-AD10-14E2ED563CEEQ33509403-37021A00-9144-40E1-BCBC-2A286756A6EEQ33566109-31F20161-E28A-4BF0-98D3-B1D6FA0FDB8FQ33566114-D57E6849-953E-48C0-9B80-6F6BF31F6A10Q33566164-2E662C86-0350-459A-8209-81B56F9F3BA7Q33587959-FD45608D-BF09-43C7-B213-7B1AF4C4937CQ33766947-54A73504-6A8C-486C-91FC-1AC451B8BDD9Q34009822-1518EC2B-E161-4891-A44F-D863BCFE6E1EQ34048663-55830744-EFFD-47DD-9A9E-4C43C49C3314Q34179419-F3112298-E0DB-45E7-8441-53CB3084928EQ34436237-4EE94237-EAD2-4CD0-AACA-C1B758ADBF93Q34531537-CD6AA6FA-BA37-42A2-9FF5-B065FA3807EDQ34613107-825D7372-C3D6-4BA1-9BD0-072E3A8CCB6CQ34661087-E0DE7379-5C14-41F2-8F31-AF51DA4918E4Q34707862-7896D9BC-CE6C-467B-84BA-C817F56D5DD2Q34758408-E5D47FAE-A4AD-48DA-90F4-3F5EE11BAC9AQ34803447-F7CF3F64-3B0F-4176-8E4E-00578E37119BQ34822450-F1DACA8D-434C-4AB4-827C-32A51772B502Q34829319-1ABD5D14-53C2-4895-9445-43A36612C954Q35065388-144142CF-492E-4944-A42C-18D7ACC711CBQ35740484-DBB6EDD5-4782-4782-B1B9-17B5D9C03C61Q35864793-7A31968C-ECBB-48BE-A1E3-21911AEBDCCCQ35955612-CA9C8670-A19F-4198-813F-5C2318729613Q35987875-2742CF76-BD85-49E1-A253-FE7436471040Q36059857-48C67920-5B62-4E19-8777-4520E6576D61Q36381682-2296F233-1203-4AAB-B15F-72A9384E4AF7Q36792091-0ED7AC1F-B83B-4AC3-8185-BC260B605DBAQ37014853-9192F4EF-DCA0-45EE-B7AD-1FC03B8C57B5Q37041949-D9FD9A90-3388-41EC-B7E7-C3DD343F420CQ37109815-A89C9946-15B6-4FA4-BCC8-231CA3842630Q37151155-293CF679-8A1E-4C41-B6D1-32AD813793BAQ37203360-35E57592-FF16-435F-978E-E47082907A6DQ37232889-4569EE71-E025-446D-84DA-850BD3D29B9D
P2860
How should DSM-V criteria for schizophrenia include cognitive impairment?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
How should DSM-V criteria for schizophrenia include cognitive impairment?
@en
type
label
How should DSM-V criteria for schizophrenia include cognitive impairment?
@en
prefLabel
How should DSM-V criteria for schizophrenia include cognitive impairment?
@en
P2860
P356
P1476
How should DSM-V criteria for schizophrenia include cognitive impairment?
@en
P2093
Richard S E Keefe
Wayne S Fenton
P2860
P304
P356
10.1093/SCHBUL/SBM046
P407
P577
2007-06-13T00:00:00Z